Poster Presentation: Identification of Tumor-Marker Gangliosides for Early Cancer Detection: A Mass Spectrometry Approach
American Association for Cancer Research (AACR)
Poster Presentation: Identification of Tumor-Marker Gangliosides for Early Cancer Detection: A Multi-Platform Approach
2024 Glycolipid and Sphingolipid Biology Gordon Research Conference
The Cancer Glycocode as a Family of Diagnostic Biomarkers, Exemplified by Tumor-Associated Gangliosides
Frontiers in Oncology
Abstract: GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of ovarian cancer
2023 American Society of Clinical Oncology (ASCO) meeting
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer
Frontiers in Oncology
Poster Presentation: GD2 and GD3 tumor gangliosides as diagnostic markers for all subtypes and stages of ovarian cancer (OC) in liquid biopsies
2023 Society of Gynecologic Oncology Annual Meeting on Women's Cancer
Tumor Glycolipids, a New Frontier for Early Detection and Precision Medicine in Ovarian Cancer and Other Malignancies
The Journal of Precision Medicine
GD2 and GD3 tumor gangliosides as diagnostic markers for all subtypes and stages of ovarian cancer (OC) in liquid biopsies
2022 Early Detection of Cancer Conference
Aiming for the Sweet Spot: Glyco-Immune Checkpoints and gd T Cells in Targeted Immunotherapy
Frontiers in Immunology